The smaller, more volatile of these two companies has higher potential for significant gains. However, that also comes with a healthy dose of risk. Choosing between these two stocks may come down to ...

MRNA heads into Q1 earnings with expected sales growth, new vaccine momentum and focus on pipeline updates amid tough RSV competition.

Morgan Stanley said on Tuesday that Moderna may provide the vast majority of COVID-19 vaccine doses to the US.

Moderna has filed a lawsuit against Pfizer and its German partner BioNTech for allegedly copying their COVID-19 vaccine. On Friday, Moderna issued a news release accusing Pfizer of infringing several ...

By Blake Brittain April 24 (Reuters) - German biotech company CureVac sued Moderna in Delaware federal court on Friday, ...

U.S. Food and Drug Administration staff recommends monitoring people who get Pfizer or Moderna's Covid-19 vaccine shots for possible cases of Bell's palsy, saying it's not necessarily a side effect ...

Now that Pfizer’s COVID-19 vaccine has gotten full FDA approval, how close is Moderna’s vaccine to the same sign-off? Here's what we know so far. The Food and Drug Administration on Monday granted ...

Pfizer is by far the larger and better-established drugmaker. With a market cap of $156 billion, the pharmaceutical leader boasts a deep product portfolio across several therapeutic areas. Even with a ...